Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Water workouts may ease sickle cell struggles in kids

NCT ID NCT06939933

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether aquatic (water) exercises could improve muscle strength and quality of life in 50 children aged 6-10 with sickle cell anemia. Children did water-based activities to see if it helped their grip strength, leg and trunk muscles, and overall well-being. The goal was to find a safe way for these kids to exercise without triggering pain episodes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Nov 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The children are assigned aged from 6-10 years. * Both genders were included. * They were able to follow instructions and understand commands. * Children were free from orthopedic deformities in the upper and lower limbs. * Children were not practicing any kind of sports. * Children must have a normal body mass index (BMI) in relation to their ages. Exclusion Criteria: * Children with neurological, musculoskeletal, and cardiopulmonary diseases limit their movement. * Children with cognitive disorders. * Children suffering from auditory impairment that limit him or her from answering the questions. * Children with vaso occlusive crises. * Children who have another disease associated with SCA. * Children who had recent blood transfusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sickle cell anemia in children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eman samir shaltout

    Tanta, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.